查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1742538

急性肾损伤治疗市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Acute Kidney Injury Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 199 Pages | 商品交期: 2-10个工作天内

价格

急性肾损伤治疗市场-报告范围

TMR 的全球急性肾损伤治疗市场报告研究了过去和当前的成长趋势和机会，旨在深入了解 2025 年至 2035 年预测期内的市场指标。该报告提供了 2019 年至 2035 年期间全球急性肾损伤治疗市场的收入，以 2025 年为基准年，2035 年为预测。该报告还提供了 2025 年至 2035 年全球急性肾损伤治疗市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括分析师对关键意见领袖、产业领导者和舆论领袖进行访谈。次要研究则参考了主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解急性肾损伤治疗市场。

市场概况
2024 年的市场价值 36亿美元
2035年的市场价值 82亿美元
复合年增长率 7.8%

本报告深入探讨了全球急性肾损伤治疗市场的竞争格局。该报告确定了全球急性肾损伤治疗市场的主要参与者，并根据不同属性对每家公司进行了分析。本报告对全球急性肾损伤治疗市场参与者的属性进行了分析，包括公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球急性肾损伤治疗市场分析与预测

第五章：关键见解

  • 管道分析
  • 重点产品及品牌分析
  • 各国/地区监管情况
  • 全球主要国家疾病盛行率及发生率
  • 全球主要国家 AKI 类型死亡率
  • 新兴趋势 - 按 AKI 类型划分
    • 新药临床试验 (IND) - MTX652
    • 使用 iNPC 衍生的细胞外囊泡 (EV) 治疗 AKI
    • 早期 AKI 诊断的生物标记
    • 连续性肾臟替代疗法（CRRT）进展
    • 肾臟修復中的基因治疗
    • 西司他丁预防肾毒素引起的急性肾损伤
    • 治疗急性肾损伤 (AKI) 的候选药物 - UNI-494
    • RMC-035-IND（新药研究）
    • 人工智慧在 AKI 中的应用
    • 间质干细胞治疗
  • 竞争对手产品的基准化分析
  • 波特五力分析
  • PESTEL分析
  • 对新进者​​（主要是 OEM）的限制/挑战和主要考虑因素及商业模式的见解

第六章：全球市场分析与预测：按药物疗法

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年药物治疗市场价值预测
    • 血管收缩剂
    • 正性肌力药物
    • 利尿剂
    • 静脉注射（IV）晶体溶液
    • 免疫抑制药物
    • 其他的
  • 药物治疗的市场吸引力

第七章：全球市场分析与预测：依类型

  • 介绍和定义
  • 主要发现/进展
  • 2020-2035年各类型市场价值预测
    • 肾前性急性肾损伤
    • 肾内性急性肾损伤
    • 肾后性急性肾损伤
  • 不同类型的市场吸引力

第八章：全球市场分析与预测：按配销通路

  • 介绍和定义
  • 主要发现/进展
  • 2020-2035年配销通路市场价值预测
    • 医院药房
    • 零售药局
    • 网路药局
  • 配销通路的市场吸引力

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第十二章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太其他地区
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 各公司市占率分析（2024 年）
  • 公司简介
    • AM-Pharma
    • Aptabio Therapeutics
    • Arch Biopartners
    • Novartis AG
    • Guard Therapeutics
    • Renibus Therapeutics
    • Mission Therapeutics
    • Unicycive Therapeutics Inc.
    • Baxter International Inc.
    • ICU Medical
    • B. Braun Melsungen AG
    • Fresenius Kabi
    • Amanta Healthcare
    • Pfizer, Inc.
    • Sanofi SA
Product Code: TMRGL67523

Acute Kidney Injury Treatment Market - Scope of Report

TMR's report on the global acute kidney injury treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global acute kidney injury treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute kidney injury treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the acute kidney injury treatment market.

Market Snapshot
Market Value in 2024US$ 3.6 Bn
Market Value in 2035US$ 8.2 Bn
CAGR7.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute kidney injury treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global acute kidney injury treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute kidney injury treatment market.

The report delves into the competitive landscape of the global acute kidney injury treatment market. Key players operating in the global acute kidney injury treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global acute kidney injury treatment market profiled in this report.

Key Questions Answered in global acute kidney injury treatment Market Report:

  • What is the sales/revenue generated by acute kidney injury treatment across all regions during the forecast period?
  • What are the opportunities in the global acute kidney injury treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Acute Kidney Injury Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global acute kidney injury treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global acute kidney injury treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global acute kidney injury treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Acute Kidney Injury Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product & Brand Analysis
  • 5.3. Regulatory Scenario by Country/Region
  • 5.4. Disease Prevalence & Incidence Rate globally with key countries
  • 5.5. Mortality Rate by Type of AKI- globally with key Countries
  • 5.6. Emerging Trends - By Type of AKI
    • 5.6.1. Investigational New Drug (IND) - MTX652
    • 5.6.2. Extracellular Vesicle (EV) Therapy for AKI using iNPC-derived EV
    • 5.6.3. Biomarkers for Early AKI Diagnosis
    • 5.6.4. Continuous Renal Replacement Therapy (CRRT) Advancements
    • 5.6.5. Gene Therapy in Kidney Repair
    • 5.6.6. Prevention Of NephroToxin induced Acute Kidney injury with Cilastatin
    • 5.6.7. Drug Candidate For the Treatment of AKI - UNI-494
    • 5.6.8. RMC-035-IND (Investigational New Drug)
    • 5.6.9. Artificial Intelligence in AKI
    • 5.6.10. Mesenchymal Stem Cell Therapy
  • 5.7. Benchmarking of the Products Offered by the Competitors
  • 5.8. Porter's Five Forces Analysis
  • 5.9. PESTEL Analysis
  • 5.10. Insights on Restraints/Challenges & Major Factors for Considerations & Business Models for New Entrants (Mainly OEMs)

6. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Drug Therapy

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Therapy, 2020-2035
    • 6.3.1. Vasoconstrictor Agents
    • 6.3.2. Inotropic Drugs
    • 6.3.3. Diuretics
    • 6.3.4. Intravenous (IV) Crystalloid Solution
    • 6.3.5. Immunosuppressive Drugs
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Drug Therapy

7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Type, 2020-2035
    • 7.3.1. Pre-renal Acute Kidney Injury
    • 7.3.2. Intrinsic renal Acute Kidney Injury
    • 7.3.3. Post-renal Acute Kidney Injury
  • 7.4. Market Attractiveness By Type

8. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Acute Kidney Injury Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 10.2.1. Vasoconstrictor Agents
    • 10.2.2. Inotropic Drugs
    • 10.2.3. Diuretics
    • 10.2.4. Intravenous (IV) Crystalloid Solution
    • 10.2.5. Immunosuppressive Drugs
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Type, 2020-2035
    • 10.3.1. Pre-renal Acute Kidney Injury
    • 10.3.2. Intrinsic renal Acute Kidney Injury
    • 10.3.3. Post-renal Acute Kidney Injury
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Therapy
    • 10.6.2. By Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Acute Kidney Injury Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 11.2.1. Vasoconstrictor Agents
    • 11.2.2. Inotropic Drugs
    • 11.2.3. Diuretics
    • 11.2.4. Intravenous (IV) Crystalloid Solution
    • 11.2.5. Immunosuppressive Drugs
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Type, 2020-2035
    • 11.3.1. Pre-renal Acute Kidney Injury
    • 11.3.2. Intrinsic renal Acute Kidney Injury
    • 11.3.3. Post-renal Acute Kidney Injury
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Therapy
    • 11.6.2. By Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Acute Kidney Injury Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 12.2.1. Vasoconstrictor Agents
    • 12.2.2. Inotropic Drugs
    • 12.2.3. Diuretics
    • 12.2.4. Intravenous (IV) Crystalloid Solution
    • 12.2.5. Immunosuppressive Drugs
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Type, 2020-2035
    • 12.3.1. Pre-renal Acute Kidney Injury
    • 12.3.2. Intrinsic renal Acute Kidney Injury
    • 12.3.3. Post-renal Acute Kidney Injury
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Therapy
    • 12.6.2. By Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country / Sub-region

13. Latin America Acute Kidney Injury Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 13.2.1. Vasoconstrictor Agents
    • 13.2.2. Inotropic Drugs
    • 13.2.3. Diuretics
    • 13.2.4. Intravenous (IV) Crystalloid Solution
    • 13.2.5. Immunosuppressive Drugs
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Type, 2020-2035
    • 13.3.1. Pre-renal Acute Kidney Injury
    • 13.3.2. Intrinsic renal Acute Kidney Injury
    • 13.3.3. Post-renal Acute Kidney Injury
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Therapy
    • 13.6.2. By Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 14.2.1. Vasoconstrictor Agents
    • 14.2.2. Inotropic Drugs
    • 14.2.3. Diuretics
    • 14.2.4. Intravenous (IV) Crystalloid Solution
    • 14.2.5. Immunosuppressive Drugs
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Type, 2020-2035
    • 14.3.1. Pre-renal Acute Kidney Injury
    • 14.3.2. Intrinsic renal Acute Kidney Injury
    • 14.3.3. Post-renal Acute Kidney Injury
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Therapy
    • 14.6.2. By Type
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. AM-Pharma
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Aptabio Therapeutics
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Arch Biopartners
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Novartis AG
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Guard Therapeutics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Renibus Therapeutics
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Mission Therapeutics
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Unicycive Therapeutics Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Baxter International Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. ICU Medical
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. B. Braun Melsungen AG
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Fresenius Kabi
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Amanta Healthcare
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pfizer, Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Financial Overview
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Sanofi S.A.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Financial Overview
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 02: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 03: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 07: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 08: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 10: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 11: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 12: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 15: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 16: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 19: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 20: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 23: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 24: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 03: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 04: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Vasoconstrictor Agents, 2020-2035
  • Figure 05: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Inotropic Drugs, 2020-2035
  • Figure 06: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Diuretics, 2020-2035
  • Figure 07: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Intravenous (IV) Crystalloid Solution, 2020-2035
  • Figure 08: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Immunosuppressive Drugs, 2020-2035
  • Figure 09: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by others, 2020-2035
  • Figure 10: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 11: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 12: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Pre-renal Acute Kidney Injury, 2020-2035
  • Figure 13: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Intrinsic renal Acute Kidney Injury, 2020-2035
  • Figure 14: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Post-renal Acute Kidney Injury, 2020-2035
  • Figure 15: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 16: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 17: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 18: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 19: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
  • Figure 20: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 22: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 23: North America - Acute Kidney Injury Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 25: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 26: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 27: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 27: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 29: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 30: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 31: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 32: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 33: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 34: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 35: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 36: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 37: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 38: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 39: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 40: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 41: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 42: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 43: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 44: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 45: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 46: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 47: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 48: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 49: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 50: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 51: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 52: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 53: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 54: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 55: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 56: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 57: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 58: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 61: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 62: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 63: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 64: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 65: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035